BlackRock Investment Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $683K | Sell |
146,838
-2,025
| -1% | -$9.42K | ﹤0.01% | 2896 |
|
2016
Q3 | $1.15M | Sell |
148,863
-224
| -0.2% | -$1.73K | ﹤0.01% | 2556 |
|
2016
Q2 | $903K | Buy |
149,087
+8,102
| +6% | +$49.1K | ﹤0.01% | 2695 |
|
2016
Q1 | $1.2M | Buy |
140,985
+17,090
| +14% | +$146K | ﹤0.01% | 2363 |
|
2015
Q4 | $1.48M | Buy |
123,895
+9
| +0% | +$107 | ﹤0.01% | 2295 |
|
2015
Q3 | $1.25M | Sell |
123,886
-1,557
| -1% | -$15.7K | ﹤0.01% | 2430 |
|
2015
Q2 | $2.08M | Buy |
125,443
+41,382
| +49% | +$686K | ﹤0.01% | 2196 |
|
2015
Q1 | $1.3M | Buy |
84,061
+6,027
| +8% | +$93.3K | ﹤0.01% | 2348 |
|
2014
Q4 | $1.24M | Buy |
78,034
+9,424
| +14% | +$149K | ﹤0.01% | 2393 |
|
2014
Q3 | $732K | Buy |
68,610
+870
| +1% | +$9.28K | ﹤0.01% | 2720 |
|
2014
Q2 | $636K | Buy |
67,740
+18,635
| +38% | +$175K | ﹤0.01% | 2893 |
|
2014
Q1 | $339K | Buy |
49,105
+6,775
| +16% | +$46.8K | ﹤0.01% | 3097 |
|
2013
Q4 | $165K | Hold |
42,330
| – | – | ﹤0.01% | 3221 |
|
2013
Q3 | $213K | Buy |
42,330
+12,182
| +40% | +$61.3K | ﹤0.01% | 3163 |
|
2013
Q2 | $193K | Buy |
+30,148
| New | +$193K | ﹤0.01% | 3162 |
|